These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
680 related articles for article (PubMed ID: 26413013)
1. Ultrasound Biomicroscopic Imaging for Interleukin-1 Receptor Antagonist-Inhibiting Atherosclerosis and Markers of Inflammation in Atherosclerotic Development in Apolipoprotein-E Knockout Mice. Li RJ; Sun Y; Wang Q; Yang J; Yang Y; Song L; Wang Z; Luo XH; Su RJ Tex Heart Inst J; 2015 Aug; 42(4):319-26. PubMed ID: 26413013 [TBL] [Abstract][Full Text] [Related]
2. Micro-ultrasonographic imaging of atherosclerotic progression and correlation with inflammatory markers in apolipoprotein-E knockout mice. Li RJ; Yang Y; Wang YH; Xie JJ; Song L; Wang Z; Zhang YZ; Qin YW; Li ZA; Zhang XS Tex Heart Inst J; 2011; 38(4):364-70. PubMed ID: 21841862 [TBL] [Abstract][Full Text] [Related]
3. Downregulations of CD36 and Calpain-1, Inflammation, and Atherosclerosis by Simvastatin in Apolipoprotein E Knockout Mice. Yin M; Liu Q; Yu L; Yang Y; Lu M; Wang H; Luo D; Rong X; Tang F; Guo J J Vasc Res; 2017; 54(3):123-130. PubMed ID: 28448973 [TBL] [Abstract][Full Text] [Related]
4. Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta. Butcher MJ; Waseem TC; Galkina EV Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1496-506. PubMed ID: 27365405 [TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 receptor type-1 in non-hematopoietic cells is the target for the pro-atherogenic effects of interleukin-1 in apoE-deficient mice. Shemesh S; Kamari Y; Shaish A; Olteanu S; Kandel-Kfir M; Almog T; Grosskopf I; Apte RN; Harats D Atherosclerosis; 2012 Jun; 222(2):329-36. PubMed ID: 22236482 [TBL] [Abstract][Full Text] [Related]
6. The intervention effect of zinc supplementation on irbesartan treatment for atherosclerosis of ApoE-/- mice. Li S; Wang K; Xu G; Ji J; Qin C Pak J Pharm Sci; 2016 Nov; 29(6):1907-1912. PubMed ID: 28375105 [TBL] [Abstract][Full Text] [Related]
7. EphA2 knockdown attenuates atherosclerotic lesion development in ApoE(-/-) mice. Jiang H; Li X; Zhang X; Liu Y; Huang S; Wang X Cardiovasc Pathol; 2014; 23(3):169-74. PubMed ID: 24561077 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice. Merhi-Soussi F; Kwak BR; Magne D; Chadjichristos C; Berti M; Pelli G; James RW; Mach F; Gabay C Cardiovasc Res; 2005 Jun; 66(3):583-93. PubMed ID: 15914123 [TBL] [Abstract][Full Text] [Related]
10. Imbalanced gp130 signalling in ApoE-deficient mice protects against atherosclerosis. Jones GW; McLeod L; Kennedy CL; Bozinovski S; Najdovska M; Jenkins BJ Atherosclerosis; 2015 Feb; 238(2):321-8. PubMed ID: 25545330 [TBL] [Abstract][Full Text] [Related]
11. The nitroxide radical TEMPOL prevents obesity, hyperlipidaemia, elevation of inflammatory cytokines, and modulates atherosclerotic plaque composition in apoE-/- mice. Kim CH; Mitchell JB; Bursill CA; Sowers AL; Thetford A; Cook JA; van Reyk DM; Davies MJ Atherosclerosis; 2015 May; 240(1):234-41. PubMed ID: 25818249 [TBL] [Abstract][Full Text] [Related]
12. Fibronectin Splicing Variants Containing Extra Domain A Promote Atherosclerosis in Mice Through Toll-Like Receptor 4. Doddapattar P; Gandhi C; Prakash P; Dhanesha N; Grumbach IM; Dailey ME; Lentz SR; Chauhan AK Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2391-400. PubMed ID: 26427793 [TBL] [Abstract][Full Text] [Related]
13. Orthopedic surgery increases atherosclerotic lesions and necrotic core area in ApoE-/- mice. Fuijkschot WW; Morrison MC; van der Linden R; Krijnen PAJ; Zethof IPA; Theyse LFH; Kleemann R; Niessen HWM; Smulders YM Atherosclerosis; 2016 Dec; 255():164-170. PubMed ID: 27825629 [TBL] [Abstract][Full Text] [Related]
14. NaoXinTong Inhibits the Advanced Atherosclerosis and Enhances the Plaque Stability in Apolipoprotein E Deficient Mice. Yang X; Sun L; Li Y; Ma C; Yang J; Zhang W; Zhao B; Jia L; Duan Y; Han J; Li X; Chen Y J Cardiovasc Pharmacol; 2016 Mar; 67(3):203-11. PubMed ID: 26485209 [TBL] [Abstract][Full Text] [Related]
15. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice. Grandoch M; Feldmann K; Göthert JR; Dick LS; Homann S; Klatt C; Bayer JK; Waldheim JN; Rabausch B; Nagy N; Oberhuber A; Deenen R; Köhrer K; Lehr S; Homey B; Pfeffer K; Fischer JW Circ Res; 2015 Apr; 116(8):e57-68. PubMed ID: 25740843 [TBL] [Abstract][Full Text] [Related]
16. Inflammation contributes to the atherogenic role of intermittent hypoxia in apolipoprotein-E knock out mice. Arnaud C; Poulain L; Lévy P; Dematteis M Atherosclerosis; 2011 Dec; 219(2):425-31. PubMed ID: 21917260 [TBL] [Abstract][Full Text] [Related]
17. IL-9 aggravates the development of atherosclerosis in ApoE-/- mice. Zhang W; Tang T; Nie D; Wen S; Jia C; Zhu Z; Xia N; Nie S; Zhou S; Jiao J; Dong W; Lv B; Xu T; Sun B; Lu Y; Li Y; Cheng L; Liao Y; Cheng X Cardiovasc Res; 2015 Jun; 106(3):453-64. PubMed ID: 25784693 [TBL] [Abstract][Full Text] [Related]
18. Loss of Biglycan Enhances Thrombin Generation in Apolipoprotein E-Deficient Mice: Implications for Inflammation and Atherosclerosis. Grandoch M; Kohlmorgen C; Melchior-Becker A; Feldmann K; Homann S; Müller J; Kiene LS; Zeng-Brouwers J; Schmitz F; Nagy N; Polzin A; Gowert NS; Elvers M; Skroblin P; Yin X; Mayr M; Schaefer L; Tannock LR; Fischer JW Arterioscler Thromb Vasc Biol; 2016 May; 36(5):e41-50. PubMed ID: 27034473 [TBL] [Abstract][Full Text] [Related]
19. Effects of atorvastatin and diet interventions on atherosclerotic plaque inflammation and [ Hellberg S; Sippola S; Liljenbäck H; Virta J; Silvola JMU; Ståhle M; Savisto N; Metso J; Jauhiainen M; Saukko P; Ylä-Herttuala S; Nuutila P; Knuuti J; Roivainen A; Saraste A Atherosclerosis; 2017 Aug; 263():369-376. PubMed ID: 28457625 [TBL] [Abstract][Full Text] [Related]